NCT04515043 2021-06-01EXPLORATORY STUDY Addendum to INVAC1-CT-101 (NCT02301754)InvectysPhase 1 Completed6 enrolled
NCT01521780 2015-11-02Characterization of Baseline Biomarker Variability in Participants With Hepatocellular Carcinoma (MK-0000-215)Merck Sharp & Dohme LLCPhase 1 Terminated12 enrolled 7 charts